Merck 2008 Annual Report Download - page 79

Download and view the complete annual report

Please find page 79 of the 2008 Merck annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 153

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152
  • 153

Segment Reporting
Notes to the Segment Reporting: see page 123
€ million Merck Serono
Consumer
Health Care Pharmaceuticals Liquid Crystals
Performance &
Life Science Chemicals
2008 2007 2008 2007 2008 2007 2008 2007 2008 2007
Sales 4,649.6 4,187.0 439.9 418.2 5,089.5 4,605.2 864.6 909.4 1,240.9 1,231.3
Royalty income 337.2 270.7 1.8 1.5 339.0 272.2 12.3 6.3 5.1 3.5
Total revenues 4,986.8 4,457.7 441.7 419.7 5,428.5 4,877.4 876.9 915.7 1,246.0 1,234.8
Gross margin 4,191.3 3,764.7 293.7 283.7 4,485.0 4,048.4 540.6 611.3 629.1 615.1
Selling. general
and administration 1,958.9 1,980.9 213.4 210.0 2,172.3 2,190.9 61.4 –42.5 –401.4 –409.9
Research and
development –1,074.4 –878.6 –16.8 12.0 –1,091.2 890.6 84.8 –78.8 58.4–58.3
Operating result 593.7 356.9 61.3 59.6 655.0 416.5 391.2 486.6 166.5 144.4
Exceptional items –354.0 –743.6 –354.0 –743.6 46.0
Earnings before
interest and tax (EBIT) 239.7 386.7 61.3 59.6 301.0 327.1 391.2 486.6 120.5 144.4
Net operating
assets 10,355.9 9,884.8 325.9 281.0 10,681.8 10,165.8 944.3 915.1 1,127.71,053.0
Segment
liabilities 972.1 –799.0 62.6 54.5 –1,034.7 853.5 98.2 90.0 –173.6 –176.9
Capital spending
on property. plant
and equipment 235.4 147.6 14.1 6.1 249.5 153.7 64.5 48.6 78.9 57.9
Investments in
intangible assets 123.2 91.7 2.4 0.8 125.6 92.5 2.0 1.5 3.4 7.5
Net cash flows
from operating
activities 926.8 875.9 45.6 50.9 972.4 926.8 472.7 474.0 146.5 181.1
Net cash flows
from investing
activities 373.1 –7,381.0 40.0 4.0 413.1 –7,385.0 –70.6 49.2 88.8 49.3
Free cash flow * 553.8 6,505.1 5.6 46.9 559.4 6,458.2 402.1 424.8 57.7 131.8
Impairment losses –338.8 100.2 338.8 100.2 –0.6 –0.2 –6.1 –8.9
€ million
Germany France Switzerland Rest of Europe
2008 2007 2008 2007 2008 2007 2008 2007
Sales by customer location 722.2 711.2 779.0 737.8 77.9 75.7 1,944.4 1,797.2
Sales by company 1,093.1 1,050.5 885.5 847.9 197.9 184.3 1,643.8 1,495.9
Total revenues 1,109.6 1,061.7 892.0 854.5 441.4 382.0 1,644.5 1,496.0
Intragroup sales with other regions 1,604.0 1,444.5 129.9 115.5 2,038.6 1,875.6 932.7 820.6
Operating result 382.4 483.5 262.3 174.2 –966.5 1,002.8 615.6 551.6
Exceptional items –16.1 32.0 –11.9 1.9 244.1 734.0 26.8 –11.5
Earnings before interest and tax (EBIT) 239.5 451.5 250.5 176.1 –1,210.6 –1,736.8 588.8 540.1
Net operating assets 1,870.1 2,027.6 458.5 559.0 8,049.5 6,939.9 984.0 975.0
Capital spending on property,
plant and equipment 160.4 128.9 12.4 13.9 118.5 43.9 40.1 25.8
Investments in intangible assets 73.2 36.0 2.1 34.0 43.6 3.2 5.8
Research and development 571.1 445.6 55.0 92.3 558.7 476.2 31.6 –24.2
Number of employees 10,301 10,142 2,364 2,415 2,090 1,812 4,351 4,561
* including Discontinued operations
74 | Merck Annual Report 2008